Miami Cancer Institute, Baptist Health South Florida — Miami, Florida

Miami Cancer Institute, Baptist Health South Florida is a clinical research site located in Miami, Florida, United States 33176.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Miami Cancer Institute, Baptist Health South Florida has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Bladder Cancer, Urothelial Carcinoma, Metastatic Urothelial Carcinoma.

Sponsors: pharmaand GmbH, GT Medical Technologies, Inc., Daiichi Sankyo.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Miami Cancer Institute, Baptist Health South Florida?

Miami Cancer Institute, Baptist Health South Florida has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Miami Cancer Institute, Baptist Health South Florida conducted?

Miami Cancer Institute, Baptist Health South Florida has 3 clinical trials on record, with 1 currently active. Their work covers Bladder Cancer, Urothelial Carcinoma, Metastatic Urothelial Carcinoma.

Is Miami Cancer Institute, Baptist Health South Florida accredited by Crixeo Health?

Miami Cancer Institute, Baptist Health South Florida has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Miami Cancer Institute, Baptist Health South Florida?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.